Article - 25/02/2013 Microalgae can produce more than just fuel Microalgae have played an important role as animal feed or food supplements for decades. They can also produce complex chemical compounds. This so-called material use of microalgae is already a major economic sector. However, when it comes to algal biotechnology, they are almost universally seen as just energy sources.https://www.gesundheitsindustrie-bw.de/en/article/news/microalgae-can-produce-more-than-just-fuel
Article - 22/02/2013 Malte Drescher provides insights into cells Electron spin resonance (ESR) spectroscopy can deliver information about the structure and dynamics of large molecules and was used by Dr. Malte Drescher from the University of Konstanz to develop a method for the structural analysis of biological macromolecules inside cells. It provides insights into the complex structure of molecules under physiological conditions and is a promising approach for the development of cancer drugs.https://www.gesundheitsindustrie-bw.de/en/article/news/malte-drescher-provides-insights-into-cells
Article - 18/02/2013 Biotechnology in Biberach: a success story that breaks new ground At its New Year reception Biberach University of Applied Sciences outlined the universitys success the establishment of its biotechnology programme is going smoothly and student interest remains steady. Biberach also has a successful track record of acquiring third-party funding and has established new national and international cooperations.https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnology-in-biberach-a-success-story-that-breaks-new-ground
Article - 18/02/2013 Dickkopf deficiency improves cognitive performance Scientists from the German Cancer Research Center have shown that the Dickkopf gene, which regulates head development during embryogenesis, prevents the regeneration of nerve cells in the mouse hippocampus. This also leads to the loss of learning capacity in advanced age. Animals in advanced adult age whose Dickkopf gene had been silenced showed no age-related decline in cognitive performance.https://www.gesundheitsindustrie-bw.de/en/article/news/dickkopf-deficiency-improves-cognitive-performance
Article - 18/02/2013 AIDS researchers from Ulm to shed light on the success of the HIV-1 M group Frank Kirchhoff AIDS researcher at the University of Ulm has come up with a plausible explanation for the pandemic spread of the human immunodeficiency virus 1 HIV-1 M group and its ability to adapt to the human immune system. In a recent study with colleagues from Germany and abroad Kirchhoff used molecular biology methods to investigate the group and compare it with the relatively rare HIV-1 N group. Kirchhoff hopes that the molecular…https://www.gesundheitsindustrie-bw.de/en/article/news/aids-researchers-from-ulm-to-shed-light-on-the-success-of-the-hiv-1-m-group
Article - 11/02/2013 REGiNA – the health region for regenerative medicine REGiNA is a users’ centre for regenerative medicine in the area bordered by the cities of Stuttgart and Tübingen and the Neckar-Alb region. It was established with the aim of translating a variety of advanced regenerative methods into broad clinical application. Providing a diverse and broad range of information, REGiNA is focused on making new treatment possibilities and the opportunities created by regenerative medicine known to doctors,…https://www.gesundheitsindustrie-bw.de/en/article/news/regina-the-health-region-for-regenerative-medicine
Article - 11/02/2013 Quality management: burden or opportunity? Companies are facing increasing demands. Globalisation and an increasingly quality-conscious market increase competition and pricing pressure. To remain globally competitive companies need a product and service quality that will satisfy the customer in the long term. Alexander Cansier managing director of OrgaConnect GmbH has specialised in the support of small and medium-sized companies in the life sciences pharmaceutical and medical technology…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-management-burden-or-opportunity
Article - 11/02/2013 Cholesterol boosts the memory of the immune system Cholesterol has been demonised for a long time as high cholesterol levels are seen as major risk factors for atherosclerosis myocardial infarction and gallstones. However cholesterol is an essential component of mammalian cell membranes and is required for proper membrane function. It exists in huge quantities in the human body. In addition to being essential for cell survival and hence all animal life in general cholesterol also plays a crucial…https://www.gesundheitsindustrie-bw.de/en/article/news/cholesterol-boosts-the-memory-of-the-immune-system
Article - 11/02/2013 Johannes Krause examines historical pathogens: old pathogens in a new light Palaeogeneticist Johannes Krause is drawn to ancient DNA. His work on the evolution of human pathogens shows that his findings are not purely of historical interest, but also enable conclusions to be made on future disease outbreaks and epidemics. In autumn 2012, Krause was awarded an ERC Starting Grant. Krause uses the grant to expand his research into plague and other historical pathogens that continue to be a threat to human health. https://www.gesundheitsindustrie-bw.de/en/article/news/johannes-krause-examines-historical-pathogens-old-pathogens-in-a-new-light
Article - 11/02/2013 The Human Brain Project The Human Brain Project has been granted funding under the EU’s multi-billion euro competition, Future and Emerging Technolgies (FET). The project will receive funds of over one billion euros for a period of ten years and endeavour to simulate the human brain using newly developed supercomputers. https://www.gesundheitsindustrie-bw.de/en/article/news/the-human-brain-project
Article - 04/02/2013 capmatch medical – financing network for life sciences start-ups and investors “capmatch medical” was specifically designed for young medical device and biotech companies that are seeking capital from investors in Europe. Combined with professional coaching and process management, capmatch medical’s matching approach improves the chances of successful matchmaking between companies and dedicated investors. https://www.gesundheitsindustrie-bw.de/en/article/news/capmatch-medical-financing-network-for-life-sciences-start-ups-and-investors
Article - 04/02/2013 DKFZ-HIPO – the Heidelberg Center for Personalised Oncology The German Cancer Research Center (DKFZ) and the National Center for Tumour Diseases (NCT) have jointly initiated the Heidelberg Center for Personalised Oncology (HIPO) which provides cancer patients with high-throughput genetic and molecular analyses. In anticipation of the upcoming World Cancer Day on 4th February 2013, the potential of high-throughput genetic and molecular analyses in improving cancer therapy was presented at a workshop held…https://www.gesundheitsindustrie-bw.de/en/article/news/dkfz-hipo-the-heidelberg-center-for-personalised-oncology
Article - 04/02/2013 SYGNIS Pharma - the "new" one: development and commercialisation of molecular diagnostics products Heidelberg-based SYGNIS Pharma AG is to discontinue its therapeutic R&D projects targeting human nervous system diseases and will in future focus on the research and development of novel molecular biology technologies, including DNA amplification and sequencing as well as drug screening.https://www.gesundheitsindustrie-bw.de/en/article/news/sygnis-pharma-the-new-one-development-and-commercialisation-of-molecular-diagnostics-products
Article - 04/02/2013 G protein-coupled receptors and their importance for research and development Brian Kobilka and Robert Lefkowitz were awarded the 2012 Nobel Prize in Chemistry for their groundbreaking discoveries of the inner workings of G protein-coupled receptors (GPCRs). These transmembrane receptors play a key role in the processing of odours and the recognition of hormones. The work of the two American scientists has had an impact on many researchers around the world. In the following interview, Professor Dr. Daniel Legler, head of…https://www.gesundheitsindustrie-bw.de/en/article/news/g-protein-coupled-receptors-and-their-importance-for-research-and-development
Article - 04/02/2013 Combining bio- and medtech for the diagnosis of cardiac diseases The Department of Cardiology at Heidelberg University Hospital and Siemens Corporate Technology have been working together since 2011 to develop new software that improves the diagnosis of heart diseases. The new software analyses and manages data related to the genetic causes of cardiomyopathy and presents the data to physicians in a clear manner. Specific microRNAs in the blood of patients have the potential of being used as new biomarkers,…https://www.gesundheitsindustrie-bw.de/en/article/news/combining-bio-and-medtech-for-the-diagnosis-of-cardiac-diseases
Article - 28/01/2013 Epigenetics and childhood blood cancer Juvenile myelomonocytic leukaemia JMML is the most common chronic cancer of the blood in children and tends to have a poor response to chemotherapy. Prof. Dr. Christian Flotho and his team from the Centre of Paediatric and Adolescent Medicine in Freiburg have shown that epigenetic mechanisms play a key role in the pathogenesis of JMML. As part of a German Research Foundation priority programme the researchers from Freiburg are working on…https://www.gesundheitsindustrie-bw.de/en/article/news/epigenetics-and-childhood-blood-cancer
Article - 28/01/2013 Dietmar Thal and the Alzheimer ABC The initial consensus guidelines for the postmortem diagnosis of Alzheimer’s disease were published in 1997. In the same year, Dietmar Thal started his four-year research project at the Institute of Anatomy at the University of Frankfurt under the supervision of Heiko Braak, who was then one of the leading figures in Alzheimer’s research, notably for his achievements in grading the presence and distribution of tau tangles in the brain in 1991. In…https://www.gesundheitsindustrie-bw.de/en/article/news/dietmar-thal-and-the-alzheimer-abc
Article - 21/01/2013 Mannheim Institute of Biological Process Engineering turns 25 The Institute of Biological Process Engineering (IBV) at the Mannheim University of Applied Sciences has been focusing on sustainable products and methods modelled on nature for 25 years. The institute will celebrate its 25th anniversary on the university campus at the end of the 2013 summer semester.https://www.gesundheitsindustrie-bw.de/en/article/news/mannheim-institute-of-biological-process-engineering-turns-25
Article - 21/01/2013 Early warning signals of ageing in stem cells The large international project SyStemAge is specifically focused on the role of stem cells in ageing and age-related diseases. Coordinated by the European Molecular Biology Laboratory and the Heidelberg University Hospital the SyStemAge consortium seeks to identify the causes and molecular pathways associated with the processes of ageing on the stem-cell level as well as developing novel strategies for the early treatment of age-related…https://www.gesundheitsindustrie-bw.de/en/article/news/early-warning-signals-of-ageing-in-stem-cells
Article - 14/01/2013 A Heidelberg man of African origin The lower jaw of Homo heidelbergensis was an isolated find and has long been overshadowed by other spectacular early human finds. Homo heidelbergensis is regarded as the last common ancestor of Neanderthals and Homo sapiens, and so is a central part of the debate on modern human origins.https://www.gesundheitsindustrie-bw.de/en/article/news/a-heidelberg-man-of-african-origin
Article - 14/01/2013 Boehringer takes a deep breath: a look into the company’s respiratory R&D pipeline At its 3rd International Research & Development (R&D) press conference, Boehringer Ingelheim gave journalists insights into its R&D pipeline. Around 200 scientists at the company’s site in Biberach are investigating new treatment options for patients with COPD (chronic obstructive pulmonary disease), asthma, idiopathic lung fibrosis, lung cancer and other respiratory diseases. In addition, the researchers are also focusing on the…https://www.gesundheitsindustrie-bw.de/en/article/news/boehringer-takes-a-deep-breath-a-look-into-the-company-s-respiratory-r-d-pipeline
Article - 07/01/2013 Small RNAs and immunological reactions Patients with common variable immunodeficiency CVID lack antibodies that would protect them against infections. Only a handful of patients develop the disease because of a single defect in any of the genes involved in CVID pathogenesis. A group of researchers led by Dr. Ulrich Salzer at the Centre for Chronic Immunodeficiency CCI at the University of Freiburg Medical Centre investigates how small RNA molecules control B-lymphocyte development as…https://www.gesundheitsindustrie-bw.de/en/article/news/small-rnas-and-immunological-reactions
Article - 07/01/2013 GlobalFlow GmbH – how smart materials management can help save resources The two GlobalFlow GmbH managing directors, Nadine Antic and Seda Erkus, only recently completed their energy and resource management and environmental technology studies and immediately set out to establish their own company. GlobalFlow GmbH, which is based in Reutlingen, offers comprehensive services related to the conservation of resources and materials management.https://www.gesundheitsindustrie-bw.de/en/article/news/globalflow-gmbh-how-smart-materials-management-can-help-save-resources
Article - 07/01/2013 HepaChip: a promising tool for assessing adverse drug effects Liver damage is one of the most common adverse drug effects. Since results obtained with animal experiments can only be transferred to the situation in humans to a limited extent, there is a need for cell-based systems that model human organ function as closely as possible. The new HepaChip, developed by researchers at the NMI in Reutlingen on the basis of human liver and endothelial cells is able to do just this.https://www.gesundheitsindustrie-bw.de/en/article/news/hepachip-a-promising-tool-for-assessing-adverse-drug-effects
Article - 31/12/2012 Diagnosis of myocardial infarction: a drop of blood is all that is required Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial…https://www.gesundheitsindustrie-bw.de/en/article/news/diagnosis-of-myocardial-infarction-a-drop-of-blood-is-all-that-is-required